Skip to main content

Coronavirus (COVID-19) Updates: Visitation Policies (New! 11.25.20) | How We're Keeping You Safe | Latest COVID Information

Coronavirus (COVID-19): Visitor Restrictions, Resources, and Updates

Explore URMC
menu
URMC / Research / Clinical Trials / Study Details

UGUK17036 / Fung RCC Carevive Pilot IIT / Chunkit Fung

Research Question:
Will a computer-based method of at-home symptom reporting and management be feasible to implement among patients with metastatic renal cell carcinoma (RCC)?

Basic Study Information

Purpose:
To determine if Carevive software, which monitors treatment-related toxicities and then generates self-care management plans for these symptoms, will be feasible to implement among patients with metastatic renal cell carcinoma (RCC). Additionally for collection of preliminary data on treatment-related toxicities, quality of life, distress level, and drug adherence.

Location: University of Rochester Medical Center
Study Reference #: UGUK17036

Lead Researcher (Principal Investigator)

Lead Researcher:  Chunkit Fung

Study Contact Information

Study Coordinator: Jessica Mackowiak
Email: jessica_ellis@urmc.rochester.edu

Additional Study Details

Learn More About These Conditions

More information about Carcinoma, Renal Cell

More information about Kidney Cancer

Return to Search